(Circulation. 1995;92:3453-3463.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Medicine B (S.C., S.M.A., F.V.S.-H., S.H., H.K., K.S.) and the Copenhagen City Heart Study, Epidemiological Research Unit, Department 7121, and the Department of Clinical Physiology and Nuclear Medicine (J.T.), Rigshospitalet, University of Copenhagen (Denmark).
Correspondence to Steen Carstensen, MD, Department of Medicine B 2142, Rigshospitalet, University of Copenhagen, Blegdamsvej 9, Copenhagen DK-2100, Denmark.
Background Interpretation of dobutamine-atropine stress echocardiography (DASE) is based on the assumption that the normal response to dobutamine-atropine infusion is characterized by increased systolic thickening and motion of the left ventricular (LV) walls, whereas a reduction or no change is considered indicative of coronary artery disease. The aim of this study was to quantitatively assess changes in LV dimension and wall motion patterns during DASE in a healthy population.
Methods and Results Forty-two asymptomatic voluntary subjects (22 men) with a mean age of 59 years (range, 31 to 79 years) and a likelihood of <5% for coronary artery disease underwent DASE with digital recording of two-dimensional and M-mode echocardiography at baseline and low-dose and peak infusion rates. Mean end-diastolic and end-systolic LV diameters and areas decreased and wall thicknesses increased progressively throughout the test. Wall motion and thickening increased from baseline to low-dose infusion in nearly all subjects. However, from low-dose to peak infusion, the mean absolute wall motion and relative wall thickening decreased by 13.1% (95% CI, 2.7 to 23.5) and 21.4% (95% CI, 6.4 to 36.4) regardless of age, sex, or use of atropine. Changes in fractional shortening and absolute wall thickening varied considerably, with a decrease observed in 15 and 13 individuals (36% and 31%), respectively.
Conclusions In healthy subjects, measures of wall motion and wall thickening increased from baseline to low-dose infusion but decreased from low-dose to peak infusion. These findings call for revision of the assumptions on which the common analysis of DASE is based.
Key Words: echocardiography stress dobutamine
This article has been cited by other articles:
![]() |
R. Sicari, P. Nihoyannopoulos, A. Evangelista, J. Kasprzak, P. Lancellotti, D. Poldermans, J.-U. Voigt, J. L. Zamorano, and on behalf of the European Association of Echocardi Stress echocardiography expert consensus statement: European Association of Echocardiography (EAE) (a registered branch of the ESC) Eur J Echocardiogr, July 1, 2008; 9(4): 415 - 437. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Paetsch, D. Foll, A. Kaluza, R. Luechinger, M. Stuber, A. Bornstedt, A. Wahl, E. Fleck, and E. Nagel Magnetic resonance stress tagging in ischemic heart disease Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2708 - H2714. [Abstract] [Full Text] [PDF] |
||||
![]() |
S Carstensen, U Host, K Saunamaki, and H Kelbaek Quantitative analysis of dobutamine-atropine stress echocardiography Eur J Echocardiogr, September 1, 2003; 4(3): 169 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hoffmann, T.H. Marwick, D. Poldermans, H. Lethen, R. Ciani, P. van der Meer, H.-P. Tries, P. Gianfagna, P. Fioretti, J.J. Bax, et al. Refinements in stress echocardiographic techniques improve inter-institutional agreement in interpretation of dobutamine stress echocardiograms Eur. Heart J., May 2, 2002; 23(10): 821 - 829. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. F. Kofoed, R. Bangsgaard, S. Carstensen, J. H. Svendsen, P. R. Hansen, H. Arendrup, B. Hesse, and H. Kelbaek Prolonged ischemic heart disease and coronary artery bypass -- relation to contractile reserve Eur. J. Cardiothorac. Surg., March 1, 2002; 21(3): 417 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.L Geleijnse, C Vigna, J.D Kasprzak, R Rambaldi, M.P Salvatori, A Elhendy, J.H Cornel, P.M Fioretti, and J.R.T.C Roelandt Usefulness and limitations of dobutamine-atropine stress echocardiography for the diagnosis of coronary artery disease in patients with left bundle branch block. A multicentre study Eur. Heart J., October 2, 2000; 21(20): 1666 - 1673. [Abstract] [PDF] |
||||
![]() |
D. A. Calnon, D. K. Glover, G. A. Beller, G. Vanzetto, W. H. Smith, D. D. Watson, and M. Ruiz Effects of Dobutamine Stress on Myocardial Blood Flow, 99mTc Sestamibi Uptake, and Systolic Wall Thickening in the Presence of Coronary Artery Stenoses : Implications for Dobutamine Stress Testing Circulation, October 7, 1997; 96(7): 2353 - 2360. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1995 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |